This page in English

Jessica Carlsson

Befattning: Affilierad forskare Organisation: Institutionen för medicinska vetenskaper

E-post: -

Telefon: Telefonnummer saknas

Rum: -

Forskningsämne

Biomedicin

Om Jessica Carlsson

Jessica Carlsson är docent i biomedicin vid Örebro Universitet och forskare i forskargrupperna Urologiska sjukdomar, Cancerepidemiologi samt Cirkulerande biomarkörer för detektion och monitorering av cancer.

Forskning

Jessicas forskning handlar främst om immunförsvarets roll vid vid utveckling och progression av urologiska cancerformer så som prostatacancer, njurcancer, peniscancer och cancer i urinblåsan. Hon är också delaktig i flera projekt där syftet är att undersöka cirkulerande biomarkörer och hur de kan användas för att detektera och monitorera lungcancer och orofarynxcancer. Målsättningen med forskningen är att identifiera nya diagnostiska och prognostiska verktyg som på sikt kan användas för att förbättra vården av cancerpatienter.

Undervisning

Jessica föreläser i statistik på programmet för biomedicinska analytiker samt på röntgensjuksköterskeprogrammet.

Forskargrupper
Publikationer

Forskargrupper

Publikationer

Artiklar i tidskrifter

Vikerfors, A. , Davidsson, S. , Carlsson, J. & Jerlström, T. (2024). Plasma Levels of Pentraxin 3: A Potential Prognostic Biomarker in Urinary Bladder Cancer Patients. International Journal of Molecular Sciences, 25 (6).
Glombik, D. , Davidsson, S. , Sandin, F. , Lambe, M. , Carlsson, J. , Sundqvist, P. & Kirrander, P. (2023). Penile cancer: long-term infectious and thromboembolic complications following lymph node dissection - a population-based study (Sweden). Acta Oncologica, 62 (5), 458-464.
Dorofte, L. , Grélaud, D. , Fiorentino, M. , Giunchi, F. , Ricci, C. , Franceschini, T. , Riefolo, M. , Davidsson, S. & et al. (2022). Low level of interobserver concordance in assessing histological subtype and tumor grade in patients with penile cancer may impair patient care. Virchows Archiv, 480 (4), 879-886.
Zelic, R. , Giunchi, F. , Fridfeldt, J. , Carlsson, J. , Davidsson, S. , Lianas, L. , Mascia, C. , Zugna, D. & et al. (2022). Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade.. Clinical Epidemiology, 14, 59-70.
Torbrand, C. , Warnolf, Å. , Glombik, D. , Davidsson, S. , Carlsson, J. , Baseckas, G. , Håkansson, U. , Trägårdh, E. & et al. (2022). Sentinel Node Identification with Hybrid Tracer-guided and Conventional Dynamic Sentinel Node Biopsy in Penile Cancer: A Prospective Study in 130 Patients from the Two National Referral Centres in Sweden. European Urology Oncology, 5 (6), 704-711.
Davidsson, S. , Huotilainen, S. , Carlsson, J. & Sundqvist, P. (2022). Soluble Levels of CD163, PD-L1, and IL-10 in Renal Cell Carcinoma Patients. Diagnostics, 12 (2).
Brady, L. , Carlsson, J. , Baird, A. , Casey, O. , Vlajnic, T. , Murchan, P. , Cormican, D. , Costigan, D. & et al. (2021). Correlation of integrated ERG/PTEN assessment with biochemical recurrence in prostate cancer. Cancer Treatment and Research Communications, 29.
Davidsson, S. , Carlsson, J. , Greenberg, L. , Wijkander, J. , Söderquist, B. & Erlandsson, A. (2021). Cutibacterium acnes Induces the Expression of Immunosuppressive Genes in Macrophages and is Associated with an Increase of Regulatory T-Cells in Prostate Cancer. Microbiology Spectrum, 9 (3).
Zelic, R. , Giunchi, F. , Lianas, L. , Mascia, C. , Zanetti, G. , Andrén, O. , Fridfeldt, J. , Carlsson, J. & et al. (2021). Interchangeability of light and virtual microscopy for histopathological evaluation of prostate cancer. Scientific Reports, 11 (1).
Qvick, A. , Stenmark, B. , Carlsson, J. , Isaksson, J. , Karlsson, C. & Helenius, G. (2021). Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer. Molecular Medicine, 27 (1).
Glombik, D. , Oxelbark, Å. , Sundqvist, P. , Carlsson, J. , Lambe, M. , Drevin, L. , Davidsson, S. & Kirrander, P. (2021). Risk of second HPV-associated cancers in men with penile cancer. Acta Oncologica, 60 (5), 667-671.
Vikerfors, A. , Davidsson, S. , Janusz, F. , Jerlström, T. & Carlsson, J. (2021). Soluble PD-L1 in Serum and Urine in Urinary Bladder Cancer Patients. Cancers, 13 (22).
Davidsson, S. , Fiorentino, M. , Giunchi, F. , Eriksson, M. , Erlandsson, A. , Sundqvist, P. & Carlsson, J. (2020). Infiltration of M2 Macrophages and Regulatory T Cells Plays a Role in Recurrence of Renal Cell Carcinoma. European Urology Open Science, 20, 62-71.
Carlsson, J. , Sundqvist, P. , Kosuta, V. , Fält, A. , Giunchi, F. , Fiorentino, M. & Davidsson, S. (2020). PD-L1 Expression is Associated With Poor Prognosis in Renal Cell Carcinoma. Applied immunohistochemistry & molecular morphology (Print), 28 (3), 213-220.
Zhu, J. , Chen, R. , Davidsson, S. , Carlsson, J. , Messing-Eriksson, A. , Fridfeldt, J. , Andrén, O. , Andersson, S. & et al. (2020). Psychological and physiological impacts of a fast-track diagnostic workup for men with suspected prostate cancer: Preliminary report from a randomized clinical trial. Cancer communications (London, England), 40 (5), 239-242.
Ugge, H. , Downer, M. K. , Carlsson, J. , Bowden, M. , Davidsson, S. , Mucci, L. A. , Fall, K. , Andersson, S. & et al. (2019). Circulating inflammation markers and prostate cancer. The Prostate, 79 (11), 1338-1346.
Zelic, R. , Zugna, D. , Bottai, M. , Andrén, O. , Fridfeldt, J. , Carlsson, J. , Davidsson, S. , Fiano, V. & et al. (2019). Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study. American Journal of Epidemiology, 188 (6), 1165-1173.
Erlandsson, A. , Carlsson, J. , Lundholm, M. , Fält, A. , Andersson, S. , Andrén, O. & Davidsson, S. (2019). M2 macrophages and regulatory T cells in lethal prostate cancer. The Prostate, 79 (4), 363-369.
Davidsson, S. , Carlsson, J. , Giunchi, F. , Harlow, A. , Kirrander, P. , Rider, J. , Fiorentino, M. & Andrén, O. (2019). PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes. European Urology Oncology, 2 (2), 214-221.
Carlsson, J. , Christiansen, J. , Davidsson, S. , Giunchi, F. , Fiorentino, M. & Sundqvist, P. (2019). The potential role of miR-126, miR-21 and miR-10b as prognostic biomarkers in renal cell carcinoma. Oncology Letters, 17 (5), 4566-4574.
Offermann, A. , Roth, D. , Hupe, M. C. , Hohensteiner, S. , Becker, F. , Joerg, V. , Carlsson, J. , Kuempers, C. & et al. (2019). TRIM24 as an independent prognostic biomarker for prostate cancer. Urologic Oncology, 37 (9).
Ugge, H. , Udumyan, R. , Carlsson, J. , Andrén, O. , Montgomery, S. , Davidsson, S. & Fall, K. (2018). Acne in late adolescence and risk of prostate cancer. International Journal of Cancer, 1580-1585.
Ugge, H. , Udumyan, R. , Carlsson, J. , Davidsson, S. , Andrén, O. , Montgomery, S. & Fall, K. (2018). Appendicitis before age 20 years is associated with an increased risk of later prostate cancer. Cancer Epidemiology, Biomarkers and Prevention, 27 (6), 660-664.
Grabowska, B. , Ulvskog, E. , Carlsson, J. , Fiorentino, M. , Giunchi, F. , Lindblad, P. & Sundqvist, P. (2018). Clinical outcome and time trends of surgically treated renal cell carcinoma between 1986 and 2010: results from a single centre in Sweden. Scandinavian journal of urology, 52 (3), 206-212.
Davidsson, S. , Andrén, O. , Ohlson, A. , Carlsson, J. , Andersson, S. , Giunchi, F. , Rider, J. R. & Fiorentino, M. (2018). FOXP3+ regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer. The Prostate, 78 (1), 40-47.
Erlandsson, A. , Carlsson, J. , Andersson, S. , Vyas, C. , Wikström, P. , Andrén, O. , Davidsson, S. & Rider, J. R. (2018). High inducible nitric oxide synthase in prostate tumor epithelium is associated with lethal prostate cancer. Scandinavian journal of urology, 52 (2), 129-133.
Carlsson, J. , Davidsson, S. , Fridfeldt, J. , Giunchi, F. , Fiano, V. , Grasso, C. , Zelic, R. , Richiardi, L. & et al. (2018). Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies. BMC Medical Research Methodology, 18 (1).
Ugge, H. , Carlsson, J. , Söderquist, B. , Fall, K. , Andrén, O. & Davidsson, S. (2018). The influence of prostatic Cutibacterium acnes infection on serum levels of IL6 and CXCL8 in prostate cancer patients. Infectious Agents and Cancer, 13.
Lu, D. , Carlsson, J. , Penney, K. L. , Davidsson, S. , Andersson, S. , Mucci, L. A. , Valdimarsdóttir, U. , Andrén, O. & et al. (2017). Expression and Genetic Variation in Neuroendocrine Signaling Pathways in Lethal and Nonlethal Prostate Cancer among Men Diagnosed with Localized Disease. Cancer Epidemiology, Biomarkers and Prevention, 26 (12), 1781-1787.
Braegelmann, J. , Kluemper, N. , Offermann, A. , Von Maessenhausen, A. , Böhm, D. , Deng, M. , Queisser, A. , Sanders, C. & et al. (2017). Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer. Clinical Cancer Research, 23 (7), 1829-1840.
Davidsson, S. , Carlsson, J. , Mölling, P. , Gashi, N. , Andrén, O. , Andersson, S. , Brzuszkiewicz, E. , Poehlein, A. & et al. (2017). Prevalence of Flp Pili-Encoding Plasmids in Cutibacterium acnes Isolates Obtained from Prostatic Tissue. Frontiers in Microbiology, 8.
Davidsson, S. , Fiorentino, M. , Giunchi, F. & Carlsson, J. (2017). The presence of PD-L1 in men with localized prostate cancer. Medical research archives, 4 (8).
Davidsson, S. , Mölling, P. , Rider, J. R. , Unemo, M. , Karlsson, M. G. , Carlsson, J. , Andersson, S. , Elgh, F. & et al. (2016). Erratum to: Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer. Infectious Agents and Cancer, 11.
Davidsson, S. , Mölling, P. , Rider, J. R. , Unemo, M. , Karlsson, M. G. , Carlsson, J. , Andersson, S. , Elgh, F. & et al. (2016). Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer. Infectious Agents and Cancer, 11.
Iglesias-Gato, D. , Wikström, P. , Tyanova, S. , Lavallee, C. , Thysell, E. , Carlsson, J. , Hägglöf, C. , Cox, J. & et al. (2016). The Proteome of Primary Prostate Cancer. European Urology, 69 (5), 942-952.
Lillsunde-Larsson, G. , Carlsson, J. , Karlsson, M. G. & Helenius, G. (2015). Evaluation of HPV Genotyping Assays for Archival Clinical Samples. Journal of Molecular Diagnostics, 17 (3), 293-301.
Persson, B. , Carringer, M. , Andren, O. , Andersson, S. , Carlsson, J. & Ljungqvist, O. (2015). Initial experiences with the enhanced recovery after surgery (ERAS (R)) protocol in open radical cystectomy. Scandinavian journal of urology, 49 (4), 302-307.
Sinnott, J. A. , Rider, J. R. , Carlsson, J. , Gerke, T. , Tyekucheva, S. , Penney, K. L. , Sesso, H. D. , Loda, M. & et al. (2015). Molecular differences in transition zone and peripheral zone prostate tumors. Carcinogenesis, 36 (6), 632-638.
Nowak, M. , Svensson, M. A. , Carlsson, J. , Vogel, W. , Kebschull, M. , Wernert, N. , Kristiansen, G. , Andren, O. & et al. (2014). Prognostic significance of phospho-histone H3 in prostate carcinoma. World journal of urology, 32 (3), 703-707.
Rueenauver, K. , Menon, R. , Svensson, M. A. , Carlsson, J. , Vogel, W. , Andrén, O. , Nowak, M. , Perner, S. & et al. (2014). Prognostic significance of YWHAZ expression in localized prostate cancer. Prostate Cancer and Prostatic Diseases, 17 (4), 310-314.
Carlsson, J. , Helenius, G. , Karlsson, M. G. , Andrén, O. , Klinga-Levan, K. & Olsson, B. (2013). Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate. BMC Cancer, 13.
Carlsson, J. , Davidsson, S. , Helenius, G. , Karlsson, M. , Lubovac, Z. , Andrén, O. , Olsson, B. & Klinga-Levan, K. (2011). A miRNA expression signature that separates between normal and malignant prostate tissues. Cancer Cell International (11), 14.
Deo, A. , Carlsson, J. & Lindlöf, A. (2011). How to choose a normalization strategy for miRNA quantitative real-time (QPCR) arrays. Journal of Bioinformatics and Computational Biology, 9 (6), 795-812.
Falck, E. , Karlsson, S. , Carlsson, J. , Helenius, G. , Karlsson, M. G. & Klinga-Levan, K. (2010). Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma. Cancer Cell International, 10.
Carlsson, J. , Helenius, G. , Karlsson, M. , Lubovac, Z. , Andrén, O. , Olsson, B. & Klinga-Levan, K. (2010). Validation of suitable endogenous control genes for expression studies of miRNA in prostate cancer tissues. Cancer Genetics and Cytogenetics, 202 (2), 71-75.

Artiklar, forskningsöversikter

Carlsson, J. & Davidsson, S. (2013). Prostate cancer and inflammation: The role of miRNAs. European Medical Journal Oncology, 56-60.

Doktorsavhandlingar, sammanläggningar

Carlsson, J. (2012). Identification of miRNA expression profiles for diagnosis and prognosis of prostate cancer. (Doctoral dissertation). (Sammanläggning) Örebro: Örebro universitet.

Konferensbidrag

Carlsson, J. , Vikerfors, A. , Frey, J. , Jerlström, T. & Davidsson, S. (2019). Is soluble PD-L1 a potential biomarker for urothelial bladder cancer?. Konferensbidrag vid Keystone Symposia Conference 2019: Cancer metastasis: The role of metabolism, immunity and the microenvironment, Florens, Italy, March 15-19, 2019.
Davidsson, S. , Sundqvist, P. , Giunchi, F. , Erlandsson, A. , Fiorentiono, M. & Carlsson, J. (2019). M2 macrophages and regulatory T cells as prognostic markers in renal cell carcinoma. Konferensbidrag vid Keystone Symposia Conference 2109: Cancer metastasis: The role of metabolism, immunity and the microenvironment, Florens, Italy, March 15—19, 2019.
Carlsson, J. , Vikerfors, A. , Frey, J. , Jerlström, T. & Davidsson, S. (2019). Är nivåer av cirkulerande CD163 associerat med kliniska parametrar för urinblåsecancer?. I: Svensk Urologi. Konferensbidrag vid Urologidagarna 2019, Västerås, Sweden, 2-4 October, 2019. (ss. 53-53). Svensk Urologisk Förening.
Carlsson, J. (2018). The Potential Role of miR-126 as a Prognostic Biomarker in Renal Cell Carcinoma. Konferensbidrag vid 3rd International Cancer Study & Therapy Conference, Rome, Italy, May 2-14, 2018.
Offermann, A. , Schneider, F. , Hupe, M. C. , Hohensteiner, S. , Becker, F. , Carlsson, J. , Kirfel, J. , Svensson, M. & et al. (2018). TRIM24 as Independent Prognostic Marker in Prostate Cancer. I: Modern Pathology. Konferensbidrag vid 107th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Vancouver, Canada, March 17-23, 2018. (ss. 372-373). Nature Publishing Group.
Rider, J. R. , Erlandsson, A. , Vyas, C. , Davidsson, S. , Carlsson, J. , Andersson, S. & Andren, O. (2017). iNOS expression and lethal prostate cancer in patients with localized disease. I: Cancer Research. Konferensbidrag vid AACR International Conference: New Frontiers in Cancer Research, Cape Town, South Africa, January 18-22, 2017. American Association for Cancer Research.
Svensson, M. A. , Nowak, M. , Vogel, W. , Carlsson, J. , Andrén, O. & Perner, S. (2014). Combination of Multiple Markers Predicts Prostate Cancer Outcome. I: Modern Pathology. Konferensbidrag vid 103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), MAR 01-07, 2014, San Diego, CA. (ss. 262A-262A). Nature Publishing Group.

Manuskript

Ugge, H. , Downer, M. K. , Carlsson, J. , Bowden, M. , Davidsson, S. , Mucci, L. A. , Fall, K. , Andersson, S. & et al. Circulating inflammation markers and prostate cancer.
Carlsson, J. , Helenius, G. , Karlsson, M. , Andrén, O. , Klinga-Levan, K. & Olsson, B. Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate.
Svensson, M. A. , Ohlson, A. , Sandblom, D. , Carlsson, J. , Andersson, S. , Andrén, O. & Rider, J. ERG rearrangement status and castration resistant prostate cancer : a prospective,population-based study.